Equities analysts predict that Care.com Inc (NYSE:CRCM) will announce sales of $50.81 million for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Care.com’s earnings. The highest sales estimate is $50.81 million and the lowest is $50.80 million. Care.com reported sales of $49.81 million during the same quarter last year, which indicates a positive year-over-year growth rate of 2%. The firm is expected to announce its next quarterly earnings report on Thursday, March 5th.

On average, analysts expect that Care.com will report full-year sales of $208.41 million for the current year, with estimates ranging from $208.40 million to $208.41 million. For the next year, analysts expect that the business will report sales of $224.49 million, with estimates ranging from $223.00 million to $225.86 million. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover Care.com.

Care.com (NYSE:CRCM) last posted its earnings results on Wednesday, November 6th. The information services provider reported $0.11 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.04) by $0.15. The firm had revenue of $53.29 million during the quarter, compared to the consensus estimate of $52.23 million. Care.com had a negative net margin of 9.43% and a positive return on equity of 7.48%. The firm’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.18 EPS.

A number of brokerages have recently weighed in on CRCM. Zacks Investment Research cut Care.com from a “buy” rating to a “hold” rating in a research note on Friday, October 4th. Roth Capital reiterated a “neutral” rating and issued a $10.00 price objective (down previously from $17.00) on shares of Care.com in a report on Tuesday, August 6th. Craig Hallum increased their target price on Care.com from $9.00 to $13.00 and gave the stock an “in-line” rating in a research note on Thursday, November 7th. BTIG Research upgraded Care.com from a “neutral” rating to a “buy” rating and set a $13.00 target price for the company in a report on Wednesday, August 14th. Finally, TheStreet downgraded Care.com from a “c” rating to a “d+” rating in a research report on Wednesday, August 7th. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $11.80.

NYSE:CRCM traded up $0.02 during trading hours on Friday, reaching $12.35. 3,383 shares of the stock were exchanged, compared to its average volume of 319,156. The company has a quick ratio of 2.57, a current ratio of 2.57 and a debt-to-equity ratio of 0.23. The business has a 50-day moving average of $11.64 and a two-hundred day moving average of $11.51. Care.com has a twelve month low of $7.61 and a twelve month high of $25.81. The company has a market capitalization of $415.10 million, a price-to-earnings ratio of 34.31, a PEG ratio of 6.19 and a beta of 0.99.

In other Care.com news, insider David Krupinski sold 3,120 shares of the stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $9.82, for a total value of $30,638.40. Following the sale, the insider now owns 154,635 shares of the company’s stock, valued at approximately $1,518,515.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Sheila Lirio Marcelo sold 17,090 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $9.82, for a total value of $167,823.80. Following the completion of the sale, the chief executive officer now directly owns 1,228,970 shares in the company, valued at approximately $12,068,485.40. The disclosure for this sale can be found here. Insiders sold a total of 21,488 shares of company stock valued at $211,012 in the last three months. 28.10% of the stock is currently owned by corporate insiders.

Several institutional investors have recently made changes to their positions in CRCM. JPMorgan Chase & Co. raised its holdings in Care.com by 5,040.1% in the second quarter. JPMorgan Chase & Co. now owns 249,964 shares of the information services provider’s stock valued at $2,749,000 after acquiring an additional 245,101 shares in the last quarter. Renaissance Technologies LLC grew its holdings in Care.com by 17.6% during the 2nd quarter. Renaissance Technologies LLC now owns 2,386,200 shares of the information services provider’s stock worth $26,200,000 after acquiring an additional 357,500 shares in the last quarter. Comerica Bank grew its holdings in Care.com by 8.0% during the 3rd quarter. Comerica Bank now owns 25,825 shares of the information services provider’s stock worth $288,000 after acquiring an additional 1,913 shares in the last quarter. Voloridge Investment Management LLC acquired a new stake in shares of Care.com in the 2nd quarter valued at $168,000. Finally, State of Tennessee Treasury Department raised its holdings in shares of Care.com by 4.4% in the 3rd quarter. State of Tennessee Treasury Department now owns 28,654 shares of the information services provider’s stock valued at $300,000 after purchasing an additional 1,200 shares in the last quarter. 74.35% of the stock is owned by institutional investors and hedge funds.

Care.com Company Profile

Care.com, Inc operates an online marketplace for finding and managing family care in the United States and internationally. The company helps families to address their lifecycle of care needs, including child care, senior care, and special needs care, as well as other non-medical family care needs, such as pet care, tutoring, and housekeeping; and enables caregivers to find full-time and part-time employment opportunities.

Further Reading: Oversold

Get a free copy of the Zacks research report on Care.com (CRCM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Care.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Care.com and related companies with MarketBeat.com's FREE daily email newsletter.